Diagnos Laboratorium Utama Tbk. vs Sarana Mitra Luas Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Sarana Mitra Luas Tbk. trades at Rp316 (market cap 2.73T, 28.82M 24h volume). The key difference: Sarana Mitra Luas Tbk. is far larger — about 8.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Sarana Mitra Luas Tbk. is more actively traded (28.82M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | SMIL | |
|---|---|---|
Market Cap | 310.75B | 2.73T |
Volume | 963.6K | 28.82M |
Lot | 9.64K | 288.15K |
Turnover | 217.67M | 9B |
Average Price | 225.89 | 312.44 |
Value | 217.67M | 9B |
Indicative Equilibrium Price | 226 | 316 |
Indicative Equilibrium Volume | 1K | 10.15K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Sarana Mitra Luas Tbk (the Company) was established on Sep 28, 2006 based on Notarial Deed No. 06 of Fransiska Bonita Maya Dwi Tanti, S.H., notary in Bekasi. The Company started its commercial operations in 2006.
Read more on SMIL →